CHAGRIN FALLS, Ohio, April 12, 2013 /PRNewswire/ — ORTHOWORLD, Inc., leading producer of strategic intelligence for the orthopaedic industry, announced its education curriculum for OMTEC 2013, to be held June 12-13 in Chicago.
OMTEC’s keynote panel discussion, The State and Future of U.S. FDA, brings together regulatory experts to talk about current and future FDA decisions that are impacting all stakeholders within the supply chain, including 510(k) clearance and supplier compliance. Dialogue is aimed at providing high-level actionable advice for orthopaedic device companies, contract manufacturers, investors and others.
A complementary lineup of lectures, including How to Design and Execute a Clinical Trial, Unique Device Identification Compliance, Trends in FDA Recalls and Tools for Qualifying Suppliers, delivers further insights and recommendations to orthopaedic industry professionals amidst intense regulatory scrutiny.
“OMTEC consistently attracts industry achievers,” explains April Bright , General Manager of ORTHOWORLD. “Each year I’m amazed, impressed and humbled by OMTEC’s supporters. They understand that investments in education and personal relationships yield return, especially in the absence of regulatory, political or economic certainty. Attendees and exhibitors genuinely care about the livelihood of one another and the continued health of the specialty of orthopaedics. OMTEC is proud to be the place they gather to raise the performance bar another notch.”
The first and predominant conference of its kind, OMTEC is expected to host nearly 1,000 industry professionals from across the globe. The event website, www.omtecexpo.com, provides complete details on the acclaimed educational lineup, exhibitor listings and confirmed registrants.
